As more regional governments consider ordering residents to largely stay inside their homes to try to slow the spread of the coronavirus, drug industry trade groups are pushing to ensure such orders make exceptions to allow the employees of biotech and pharma companies to travel to and from work.

The first “shelter-in-place” orders in the U.S. have come over the past few days in the Bay Area and other parts of Northern California. Local governments in Massachusetts and New York have called for similar directives; New York City’s mayor said Wednesday that one “has to be considered seriously.” Such orders confine people to their home with few exceptions, such as seeking or providing care, buying food, taking a solitary walk, or going to work for businesses that are deemed essential.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy